Decisions for lung cancer chemotherapy: the influence of physician and patient factors

[1]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[2]  G. Batist,et al.  Difficulties in decision making regarding chemotherapy for older cancer patients: A census of cancer physicians. , 2011, Critical reviews in oncology/hematology.

[3]  S. Vinod,et al.  Estimation of an optimal chemotherapy utilisation rate for lung cancer: an evidence-based benchmark for cancer care. , 2010, Lung cancer.

[4]  M. Stockler,et al.  Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review. , 2010, Lung cancer.

[5]  R. Epstein,et al.  Developing physician communication skills for patient-centered care. , 2010, Health affairs.

[6]  L. Siminoff,et al.  Differential patient-caregiver opinions of treatment and care for advanced lung cancer patients. , 2010, Social science & medicine.

[7]  M. Adachi,et al.  Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non‐small cell lung cancer , 2009, Psycho-oncology.

[8]  Dianne L. O’Connell,et al.  Gaps in Optimal Care for Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  C. Cleeland.  Symptom burden: multiple symptoms and their impact as patient-reported outcomes. , 2007, Journal of the National Cancer Institute. Monographs.

[10]  D. Chu,et al.  Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancer. , 2007, Lung cancer.

[11]  P. Butow,et al.  www.mja.com.au Supplement , 2007 .

[12]  H. Møller,et al.  Variation in the use of chemotherapy in lung cancer , 2007, British Journal of Cancer.

[13]  G. Giaccone,et al.  Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  Susan Catt,et al.  Multidisciplinary teams in cancer care: are they effective in the UK? , 2006, The Lancet. Oncology.

[15]  Thomas J. Smith,et al.  Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  D. Ball,et al.  Differences of opinion: a survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer. , 2004, Chest.

[17]  M. Hensley,et al.  Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia , 2004, Internal medicine journal.

[18]  W. Otten,et al.  Review of determinants of patients' preferences for adjuvant therapy in cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Graeff,et al.  Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice , 2003, British Journal of Cancer.

[20]  Neal J Meropol,et al.  Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  C. Ko,et al.  The need for a multidisciplinary approach to cancer care. , 2002, The Journal of surgical research.

[22]  T. Davis,et al.  Health Literacy and Cancer Communication , 2002, CA: a cancer journal for clinicians.

[23]  P. Butow,et al.  When the treatment goal is not cure: are cancer patients equipped to make informed decisions? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Brundage,et al.  Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. , 2001, Patient education and counseling.

[25]  S. Yardley,et al.  Receiving a diagnosis of lung cancer: patients' interpretations, perceptions and perspectives , 2001, Palliative medicine.

[26]  Ali Montazeri,et al.  Quality of life in lung cancer patients: as an important prognostic factor. , 2001, Lung cancer.

[27]  T. Raffin,et al.  Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States. , 2000, Chest.

[28]  M. Socinski,et al.  Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer. , 2000, Chest.

[29]  M. Weinstein,et al.  Who gets chemotherapy for metastatic lung cancer? , 2000, Chest.

[30]  G. Giles,et al.  Reported management of lung cancer in Victoria in 1993: comparison with best practice , 2000, Medical Journal of Australia.

[31]  D Feldman-Stewart,et al.  Lung cancer treatment decisions: patients’ desires for participation and information , 1999, Psycho-oncology.

[32]  H. Welch,et al.  Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews , 1998, BMJ.

[33]  E. Perez.  Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer. , 1998, Chest.

[34]  R. Bremnes,et al.  Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. , 1995, European journal of cancer.

[35]  W. Mackillop,et al.  Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  D. Cella,et al.  Someone to live for: social well-being, parenthood status, and decision-making in oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  T. Raffin,et al.  Ethical Decision Making and Patient Autonomy * , 2000 .

[38]  M. Brundage,et al.  Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.